了解癌症病情及其对重症医生的意义
Nina Buchtele1, Laveena Munshi2
1Intensive Care Unit 13i2, Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. nina.buchtele@meduniwien.ac.at.
Medizinische Klinik, Intensivmedizin und Notfallmedizin
|August 29, 2025
概括
了解癌症状况是重症患者的关键. 这种知识指导了重症监护室 (ICU) 的治疗,诊断和康复目标,
科学领域:
- 癌症学
- 危急护理医学
- 内部医学
背景情况:
- 管理危急癌症患者需要了解他们的癌症状况.
- 癌症的发展轨迹会影响严重疾病的类型,可逆性和恢复潜力,包括治疗的延续.
- 疾病状态 (新诊断,缓解,稳定,进展) 影响重症监护室 (ICU) 的差异诊断和治疗目标.
研究的目的:
- 审查瘤病情如何影响癌症患者的重症监护管理.
- 强调将癌症状况纳入ICU决策的重要性.
- 强调急诊医生和瘤学家之间合作的需要.
主要方法:
- 这是一篇综述文章.
- 它综合了有关癌症状况和重症监护的最新知识.
- 它讨论了影响预后和结果的因素.
主要成果:
- 危急癌症患者的预后取决于伴随癌症的情况和急性危急护理情况.
- 患者脆弱性,器官衰竭程度和瘤特征等因素会影响预后.
- 改善ICU存活率需要关注长期结果,例如恢复治疗和生活质量.
结论:
- 对瘤病情的全面了解对于设定现实的目标和在ICU提供量身定制的护理至关重要.
- 专科医生和瘤学家之间的密切合作有助于预测,治疗计划和提前护理讨论.
- 综合,以目标为导向的护理和共享决策改善了危急癌症患者在整个护理过程中的结果.
更多相关视频
相关概念视频
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


